Background: Defining the optimal extent of lymph node surgery in patients with melanoma and inguinal nodal disease remains clinically relevant. Inguino-iliac-obturator lymph node dissection (IILD) treats both the inguinal and iliac-obturator compartments but is associated with substantial morbidity. Identifying characteristics associated with iliac-obturator involvement may contribute to improved risk characterization and future selection of the extent of surgery. The aim of this study was to evaluate clinical, histopathological, and nodal characteristics associated with iliac-obturator metastases. Methods: Single-center retrospective observational study of 127 patients with cutaneous melanoma or melanoma of unknown primary who underwent IILD at the Veneto Institute of Oncology IOV-IRCCS between 2015 and 2025. The primary endpoint was histopathological detection of at least one metastatic iliac and/or obturator lymph node. Group comparisons and univariable logistic regressions were performed. An exploratory complete-case multivariable logistic model was also constructed, including age, sex, mitotic count, Breslow thickness, ulceration, and the number of metastatic inguinal lymph nodes. Sensitivity analyses assessed the functional form of inguinal nodal burden and excluded patients treated with neoadjuvant therapy. Results: Iliac-obturator metastases were identified in 50 of 127 patients (39.4%). The frequency of iliac-obturator involvement increased progressively with inguinal metastatic burden, from 9.3% in patients with no metastases in the excised inguinal lymph nodes to 75.0% in patients with at least three metastatic inguinal lymph nodes. In the main multivariable model (104 complete cases, 41 events), mitotic count (adjusted OR 1.11 per unit; 95% CI 1.02–1.22; p=0.022) and the number of metastatic inguinal lymph nodes (adjusted OR 1.70 per node; 95% CI 1.27–2.28; p<0.001) remained associated with iliac-obturator involvement. In the sensitivity analysis using the log2(1+n) transformation, inguinal nodal burden remained associated with the endpoint (OR 3.80 per doubling; 95% CI 2.09–6.93; p<0.001), and exclusion of patients treated with neoadjuvant therapy did not materially alter the results. Conclusions: In the multivariable model, mitotic count and the number of metastatic inguinal lymph nodes remained significantly associated with iliac-obturator involvement. However, defining inguinal metastatic burden on the basis of histopathological examination of the excised inguinal lymph nodes, with its consequent availability only in the postoperative setting, limits its usefulness for preoperative selection of surgical extent. In addition, the occurrence of iliac-obturator metastases in patients with no metastases in the excised inguinal lymph nodes and the single-center nature of the study, without confirmation in an independent cohort, do not allow definition of a predictive model or criteria for omission of the iliac-obturator component.
Extent of Lymph Node Dissection in Melanoma: Factors Associated with Iliac-Obturator Involvement and Perspectives for De-escalation
PICONE, TERESA
2024/2025
Abstract
Background: Defining the optimal extent of lymph node surgery in patients with melanoma and inguinal nodal disease remains clinically relevant. Inguino-iliac-obturator lymph node dissection (IILD) treats both the inguinal and iliac-obturator compartments but is associated with substantial morbidity. Identifying characteristics associated with iliac-obturator involvement may contribute to improved risk characterization and future selection of the extent of surgery. The aim of this study was to evaluate clinical, histopathological, and nodal characteristics associated with iliac-obturator metastases. Methods: Single-center retrospective observational study of 127 patients with cutaneous melanoma or melanoma of unknown primary who underwent IILD at the Veneto Institute of Oncology IOV-IRCCS between 2015 and 2025. The primary endpoint was histopathological detection of at least one metastatic iliac and/or obturator lymph node. Group comparisons and univariable logistic regressions were performed. An exploratory complete-case multivariable logistic model was also constructed, including age, sex, mitotic count, Breslow thickness, ulceration, and the number of metastatic inguinal lymph nodes. Sensitivity analyses assessed the functional form of inguinal nodal burden and excluded patients treated with neoadjuvant therapy. Results: Iliac-obturator metastases were identified in 50 of 127 patients (39.4%). The frequency of iliac-obturator involvement increased progressively with inguinal metastatic burden, from 9.3% in patients with no metastases in the excised inguinal lymph nodes to 75.0% in patients with at least three metastatic inguinal lymph nodes. In the main multivariable model (104 complete cases, 41 events), mitotic count (adjusted OR 1.11 per unit; 95% CI 1.02–1.22; p=0.022) and the number of metastatic inguinal lymph nodes (adjusted OR 1.70 per node; 95% CI 1.27–2.28; p<0.001) remained associated with iliac-obturator involvement. In the sensitivity analysis using the log2(1+n) transformation, inguinal nodal burden remained associated with the endpoint (OR 3.80 per doubling; 95% CI 2.09–6.93; p<0.001), and exclusion of patients treated with neoadjuvant therapy did not materially alter the results. Conclusions: In the multivariable model, mitotic count and the number of metastatic inguinal lymph nodes remained significantly associated with iliac-obturator involvement. However, defining inguinal metastatic burden on the basis of histopathological examination of the excised inguinal lymph nodes, with its consequent availability only in the postoperative setting, limits its usefulness for preoperative selection of surgical extent. In addition, the occurrence of iliac-obturator metastases in patients with no metastases in the excised inguinal lymph nodes and the single-center nature of the study, without confirmation in an independent cohort, do not allow definition of a predictive model or criteria for omission of the iliac-obturator component.| File | Dimensione | Formato | |
|---|---|---|---|
|
Picone_Teresa.pdf
Accesso riservato
Dimensione
853.19 kB
Formato
Adobe PDF
|
853.19 kB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/119696